These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 20381159)

  • 21. Venlafaxine, but not mirtazapine lowers retinol-binding protein 4 serum concentrations in nondiabetic depressed patients.
    Deuschle M; Angermeier T; Westphal S; Lederbogen F; Gilles M; Frankhauser P; Schilling C; Onken V; Weber-Hamann B; Kopf D
    Psychother Psychosom; 2010; 79(2):123-5. PubMed ID: 20090399
    [No Abstract]   [Full Text] [Related]  

  • 22. Comparison of efficacy and tolerability of reboxetine and venlafaxine XR in major depression and major depression with anxiety features: an open label study.
    Akkaya C; Sivrioglu EY; Akgoz S; Eker SS; Kirli S
    Hum Psychopharmacol; 2006 Jul; 21(5):337-45. PubMed ID: 16856215
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A randomized, double-blind comparison of duloxetine and venlafaxine in the treatment of patients with major depressive disorder.
    Perahia DG; Pritchett YL; Kajdasz DK; Bauer M; Jain R; Russell JM; Walker DJ; Spencer KA; Froud DM; Raskin J; Thase ME
    J Psychiatr Res; 2008 Jan; 42(1):22-34. PubMed ID: 17445831
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Does night-time cortisol excretion normalize in the long-term course of depression?
    Scharnholz B; Lederbogen F; Feuerhack A; Bach A; Kopf D; Frankhauser P; Onken V; Schilling C; Gilles M; Hamann B; Deuschle M
    Pharmacopsychiatry; 2010 Jul; 43(5):161-5. PubMed ID: 20191443
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Venlafaxine-mirtazapine combination in the treatment of persistent depressive illness.
    Hannan N; Hamzah Z; Akinpeloye HO; Meagher D
    J Psychopharmacol; 2007 Mar; 21(2):161-4. PubMed ID: 17329295
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Leptin plasma concentrations increase during antidepressant treatment with amitriptyline and mirtazapine, but not paroxetine and venlafaxine: leptin resistance mediated by antihistaminergic activity?
    Schilling C; Gilles M; Blum WF; Daseking E; Colla M; Weber-Hamann B; Lederbogen F; Krumm B; Heuser I; Wudy SA; Kopf D; Deuschle M
    J Clin Psychopharmacol; 2013 Feb; 33(1):99-103. PubMed ID: 23277262
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum brain-derived neurotrophic factor and glucocorticoid receptor levels in lymphocytes as markers of antidepressant response in major depressive patients: a pilot study.
    Rojas PS; Fritsch R; Rojas RA; Jara P; Fiedler JL
    Psychiatry Res; 2011 Sep; 189(2):239-45. PubMed ID: 21616544
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Body weight, the tumor necrosis factor system, and leptin production during treatment with mirtazapine or venlafaxine.
    Kraus T; Haack M; Schuld A; Hinze-Selch D; Koethe D; Pollmächer T
    Pharmacopsychiatry; 2002 Nov; 35(6):220-5. PubMed ID: 12518269
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment with mirtazapine and venlafaxine increases noradrenaline excretion in depressed patients.
    Lecei O; Lederbogen F; Gronau W; Scharnholz B; Terhardt J; Schilling C; Gilles M; Kopf D; Roth HJ; Weber-Hamann B; Deuschle M
    J Clin Psychopharmacol; 2012 Aug; 32(4):574-6. PubMed ID: 22760352
    [No Abstract]   [Full Text] [Related]  

  • 30. Mirtazapine and paroxetine in major depression: a comparison of monotherapy versus their combination from treatment initiation.
    Blier P; Gobbi G; Turcotte JE; de Montigny C; Boucher N; Hébert C; Debonnel G
    Eur Neuropsychopharmacol; 2009 Jul; 19(7):457-65. PubMed ID: 19345072
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Heart rate variability during antidepressant treatment with venlafaxine and mirtazapine.
    Terhardt J; Lederbogen F; Feuerhack A; Hamann-Weber B; Gilles M; Schilling C; Lecei O; Deuschle M
    Clin Neuropharmacol; 2013; 36(6):198-202. PubMed ID: 24201230
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lithium but not carbamazepine augments antidepressant efficacy of mirtazapine in unipolar depression: an open-label study.
    Schüle C; Baghai TC; Eser D; Nothdurfter C; Rupprecht R
    World J Biol Psychiatry; 2009; 10(4 Pt 2):390-9. PubMed ID: 18609420
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of mirtazapine treatment on serotonin transporter in blood peripheral lymphocytes of major depression patients.
    Peña S; Baccichet E; Urbina M; Carreira I; Lima L
    Int Immunopharmacol; 2005 Jun; 5(6):1069-76. PubMed ID: 15829422
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neural correlates of treatment outcome in major depression.
    Lisiecka D; Meisenzahl E; Scheuerecker J; Schoepf V; Whitty P; Chaney A; Moeller HJ; Wiesmann M; Frodl T
    Int J Neuropsychopharmacol; 2011 May; 14(4):521-34. PubMed ID: 21205435
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Suppressive effect of mirtazapine on the HPA system in acutely depressed women seems to be transient and not related to antidepressant action.
    Horstmann S; Dose T; Lucae S; Kloiber S; Menke A; Hennings J; Spieler D; Uhr M; Holsboer F; Ising M
    Psychoneuroendocrinology; 2009 Feb; 34(2):238-248. PubMed ID: 18926641
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy and tolerability of venlafaxine in geriatric outpatients with major depression: a double-blind, randomised 6-month comparative trial with citalopram.
    Allard P; Gram L; Timdahl K; Behnke K; Hanson M; Søgaard J
    Int J Geriatr Psychiatry; 2004 Dec; 19(12):1123-30. PubMed ID: 15526307
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Elevated salivary dehydroepiandrosterone-sulfate but normal cortisol levels in medicated depressed patients: preliminary findings.
    Assies J; Visser I; Nicolson NA; Eggelte TA; Wekking EM; Huyser J; Lieverse R; Schene AH
    Psychiatry Res; 2004 Sep; 128(2):117-22. PubMed ID: 15488954
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relationship between mirtazapine dose, plasma concentration, response, and side effects in clinical practice.
    Grasmäder K; Verwohlt PL; Kühn KU; Frahnert C; Hiemke C; Dragicevic A; von Widdern O; Zobel A; Maier W; Rao ML
    Pharmacopsychiatry; 2005 May; 38(3):113-7. PubMed ID: 15902580
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Achieving remission with venlafaxine and fluoxetine in major depression: its relationship to anxiety symptoms.
    Davidson JR; Meoni P; Haudiquet V; Cantillon M; Hackett D
    Depress Anxiety; 2002; 16(1):4-13. PubMed ID: 12203668
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of rapid tryptophan depletion on salivary cortisol in older people recovered from depression, and the healthy elderly.
    Porter RJ; Gallagher P; O'Brien JT
    J Psychopharmacol; 2007 Jan; 21(1):71-5. PubMed ID: 16533861
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.